Non-Hodgkin's Lymphoma Clinical Trials

398 clinical trials for Non-Hodgkin's Lymphoma across international registries, including 23 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma — RECRUITING · PHASE2
• GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial — RECRUITING
• Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing — RECRUITING
• Safety and Efficacy of KSVCBD Injection in B-cell Non-Hodgkin's Lymphoma Expressing CD19 and/or BCMA — RECRUITING · PHASE1
• Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies — RECRUITING
• The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen — RECRUITING
• CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies — RECRUITING · PHASE1
• Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE — RECRUITING · PHASE1
• Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma — RECRUITING · PHASE3
• ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome — RECRUITING
• Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT) — RECRUITING · PHASE2
• A Study of GNC-035 in Relapsed or Refractory Non-Hodgkin 's Lymphoma and Other Hematological Malignancies — RECRUITING · PHASE1
• A Study of GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma — RECRUITING · PHASE1
• Cord Blood Transplant in Adults With Blood Cancers — RECRUITING · PHASE2
• CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies — RECRUITING · PHASE1
• T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) — RECRUITING · PHASE1
• Allogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHL — RECRUITING · PHASE1
• TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL — RECRUITING · PHASE1
• Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma — RECRUITING · PHASE2
• A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHL — RECRUITING · PHASE1
• CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases — RECRUITING · PHASE1
• A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies — RECRUITING · PHASE1
• CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas — RECRUITING · PHASE1
• An open-label study to evaluate the utility of the apoptosis imaging biomarker [18F]ML-10 to assess the response to chemotherapy in patients with non Hodgkin's lymphoma. — TERMINATED · PHASE2
• Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma — ACTIVE_NOT_RECRUITING · PHASE1
• A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma — ACTIVE_NOT_RECRUITING · PHASE1
• Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT — ACTIVE_NOT_RECRUITING · PHASE1
• CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene — ACTIVE_NOT_RECRUITING · PHASE1
• High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma — ACTIVE_NOT_RECRUITING · PHASE1
• Vaccination With Flt3L, Radiation, and Poly-ICLC — COMPLETED · PHASE1
• An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial — ACTIVE_NOT_RECRUITING · PHASE3
• Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets — ACTIVE_NOT_RECRUITING · PHASE1
• Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders — COMPLETED · NA
• Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma — ACTIVE_NOT_RECRUITING · PHASE2
• Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's Lymphomas — ACTIVE_NOT_RECRUITING · PHASE2
• EBV CTLs Expressing CD30 Chimeric Receptors For CD 30+ Lymphoma — ACTIVE_NOT_RECRUITING · PHASE1
• Expanded Access to Venetoclax — OTHER
• PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study — ACTIVE_NOT_RECRUITING · PHASE1
• Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation — ACTIVE_NOT_RECRUITING · PHASE2
• Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma — COMPLETED · PHASE2
• Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID) — ACTIVE_NOT_RECRUITING · PHASE1
• Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-Hodgkin's Lymphoma — TERMINATED · PHASE2
• Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO) — ACTIVE_NOT_RECRUITING · PHASE1
• An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma — COMPLETED · PHASE1
• Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation — COMPLETED · PHASE1
• Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma — OTHER · PHASE1
• Living Conditions After Non-Hodgkin's Lymphoma in France — COMPLETED
• Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps — TERMINATED · PHASE1
• A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives — TERMINATED · PHASE2
• Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide — COMPLETED · PHASE1

Refine this search